III 

117TH CONGRESS 

1ST SESSION S. RES. 281 

Recognizing the 25th anniversary of the Foundation for the National Institutes of Health and its critical role in America’s biomedical research 

strategy by advancing biomedical research and the mission of the National Institutes of Health, the world’s premier biomedical research agency. 

IN THE SENATE OF THE UNITED STATES 

JUNE 22, 2021 

Mrs. MURRAY (for herself and Mr. BURR) submitted the following resolution; 

which was referred to the Committee on Health, Education, Labor, and 

Pensions 

RESOLUTION 

Recognizing the 25th anniversary of the Foundation for the 

National Institutes of Health and its critical role in 

America’s biomedical research strategy by advancing biomedical research and the mission of the National Institutes of Health, the world’s premier biomedical research 

agency. 

Whereas Congress chartered the Foundation for the National 

Institutes of Health (referred to in this preamble as the 

‘‘FNIH’’) to support the mission of the National Institutes of Health (referred to in this preamble as the 

‘‘NIH’’), which is to advance research in pursuit of fundamental knowledge that will lead to better health outcomes for all; 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•SRES 281 IS 

Whereas June 26, 2021, marks 25 years since FNIH commenced its work to improve health outcomes for the people of the United States by facilitating groundbreaking 

research and catalyzing innovation and discovery to answer the toughest scientific questions; 

Whereas FNIH is recognized by Congress, NIH, and the biomedical community as a model for aligning public and 

private partners around a common cause that advances 

breakthrough biomedical discoveries and improves the 

quality of people’s lives; 

Whereas, among the hundreds of programs FNIH has facilitated, the Grand Challenges in Global Health partnership, founded in collaboration with the Bill & Melinda 

Gates Foundation, achieved scientific breakthroughs 

against deadly diseases in the world’s poorest countries 

and elevated the role of FNIH as a leader in building alliances for biomedical research; 

Whereas FNIH, NIH, and the Food and Drug Administration of the Department of Health and Human Services 

launched the Accelerating Medicines Partnership as a 

public-private collaboration to pursue new methods to develop diagnostics and treatments for Alzheimer’s disease, 

type 2 diabetes, autoimmune disorders, Parkinson’s disease, and schizophrenia; 

Whereas the FNIH created a new model for clinical trials 

through initiatives to fight breast cancer and lung cancer, 

continues to bring together partners to identify, develop, 

and qualify biomarkers to improve drug discovery and 

regulatory decision making, and recognizes and supports 

trailblazing researchers, some of whom have won other 

prestigious scientific prizes, including the Nobel Prize; 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•SRES 281 IS 

Whereas FNIH supports caregivers of NIH Clinical Center 

patients through the Edmond J. Safra Family Lodge, a 

temporary residence for caregivers whose close presence 

helps to sustain patients who volunteer for NIH research 

that was constructed and is maintained by the FNIH on 

the NIH campus; 

Whereas FNIH answered NIH’s call to action to address the 

largest pandemic in a century by launching and coordinating the Accelerating COVID–19 Therapeutic Interventions and Vaccines (‘‘ACTIV’’) initiative in partnership 

with numerous government agencies, not-for-profit organizations, and biopharmaceutical companies to accelerate 

the most promising COVID–19 vaccines and treatments; 

and 

Whereas FNIH remains an indispensable institution to the 

biomedical research mission of the NIH and the people 

of the United States: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) celebrates the 25th anniversary of the 

3 Foundation for the National Institutes of Health 

4 and its critical role in advancing biomedical research 

5 and the mission of the National Institutes of Health, 

6 the world’s premier biomedical research agency; 

7 (2) applauds the Foundation for the National 

8 Institutes of Health for its leadership and ongoing 

9 efforts to advance human health outcomes through 

10 innovative public-private partnerships that achieve 

11 groundbreaking biomedical research results; 


pamtmann on DSKBC07HB2PROD with BILLS
4 

•SRES 281 IS 

1 (3) commends the Foundation for the National 

2 Institutes of Health for its efforts to address the 

3 COVID–19 pandemic through the Accelerating 

4 COVID–19 Therapeutic Interventions and Vaccines 

5 initiative and accelerate the development of the most 

6 promising treatments and vaccines for COVID–19; 

7 and 

8 (4) reiterates that the Foundation for the Na9 tional Institutes of Health, in partnership with the 

10 National Institutes of Health, is a vital and essential 

11 component of biomedical research strategy of the 

12 United States. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS